Comerica Bank
IHE icon

Comerica Bank’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Comerica Bank’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$537K Buy
6,330
+4,248
+204% +$339K ﹤0.01% 1827
2025
Q3 		$151K Sell
2,082
-40
-2% -$2.76K ﹤0.01% 2447
2025
Q2 		$139K Sell
2,122
-238
-10% -$15.5K ﹤0.01% 2485
2025
Q1 		$167K Sell
2,360
-106
-4% -$7.37K ﹤0.01% 2389
2024
Q4 		$162K Buy
2,466
+462
+23% +$31.8K ﹤0.01% 2401
2024
Q3 		$142K Buy
2,004
+21
+1% +$1.46K ﹤0.01% 2424
2024
Q2 		$132K Buy
1,983
+521
+36% +$34.1K ﹤0.01% 2434
2024
Q1 		$99.3K Sell
1,462
-1,094
-43% -$72.3K ﹤0.01% 2546
2023
Q4 		$158K Buy
2,556
+600
+31% +$35.3K ﹤0.01% 2337
2023
Q3 		$115K Buy
+1,956
New +$120K ﹤0.01% 2427

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Comerica Bank's IHE Position: Q4 2025 in Review

Comerica Bank increased its iShares US Pharmaceuticals ETF (IHE) stake by 204% in Q4 2025, buying an estimated $339K and bringing the position to 6,330 shares worth $537K. The position accounts for ﹤0.01% of the portfolio, ranked #1827.

Comerica Bank first reported a position in IHE in Q3 2023 and has held it in 10 quarters since. 178 funds tracked by Wall St. Rank hold IHE as of Q4 2025.

  • Comerica Bank held 6,330 shares of iShares US Pharmaceuticals ETF worth $537K as of Q4 2025.
  • Comerica Bank bought 4,248 iShares US Pharmaceuticals ETF shares in Q4 2025, an estimated $339K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1827 holding.
  • Comerica Bank first reported a position in iShares US Pharmaceuticals ETF in Q3 2023 and has held it in 10 quarters since.
  • 178 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.